Estrogen receptor dinucleotide (TA) polymorphism does not predict premature myocardial infarction in caucasian women

Cardiology

Volumn 99, Issue 3, 2003, Pages 163-165

  Petrovič, Daniel ^a,c   Peterlin, Borut ^b  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Estrogen receptor dinucleotide (TA) gene polymorphism; Lipid levels; Myocardial infarction

Indexed keywords

DINUCLEOTIDE; ESTROGEN; ESTROGEN RECEPTOR DINUCLEOTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEALTH STATUS; HEART INFARCTION; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REGULATORY MECHANISM; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ADULT; AGE OF ONSET; AGED; ALLELES; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DINUCLEOTIDE REPEATS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERLIPIDEMIAS; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROBABILITY; PROGNOSIS; RECEPTORS, ESTROGEN; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 0038307423     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070673     Document Type: Article

References (9)

1. Farhat MY, Lavigne MC, Ramwell PW: The vascular protective effects of estrogen. FASEB J 1996;10:615-624.
2. Sullivan JM, Vander Zwaag R, Lemp GF, Hughes JP, Maddock V, Kroetz FW, Ramanathan KB, Mirvis DM: Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988;108:358-363.
3. Mahaney MC, Blangero J, Rainwater DL, Comuzzie AG, VandeBerg JL, Stern MP, MacCluer JW, Hixson JE: A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio Family Heart Study. Segregation and linkage analyses. Arterioscler Thromb Vasc Biol 1995;15:1730-1739.
4. Lu H, Higashikata T, Inazu A, Nohara A, Yu W, Shimizu M, Mabuchi H: Association of estrogen receptor-α gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002;22:817-823.
5. Matsubara Y, Murata M, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y: Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 1997;17:3006-3012.
6. Kunnas TA, Laippala P, Penttila A, Lehtimaki T, Karhunen PJ: Association of polymorphism of human α-oestrogen receptor gene with coronary artery disease in men: A necropsy study. BMJ 2000;321:273-274.
7. Kunnas TA, Holmberg-Marttila D, Karhunen PJ: Analysis of estrogen receptor dinucleotide polymorphism by capillary gel electrophoresis with a population genetic study in 180 Finns. Hum Hered 1999;49:142-145.
8. Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL, Brosnihan KB, Meyers DA, Bleecker ER: Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. N Engl J Med 2002;346:967-974.
9. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DR Jr, Bangdiwala S, Tyroler HA: High-density lipoprotein cholesterol and cardiovascular disease: Four prospective American studies. Circulation 1989;79:8-15.